StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Aggregate of 14 sell-side ratings as of 2026-05-01. Stonvex does not endorse these ratings.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $44.29 | $42.80 | -3.36% | 1.3M |
| 05-18 | $43.49 | $44.45 | +2.21% | 1.7M |
| 05-19 | $43.72 | $42.60 | -2.56% | 1.0M |
| 05-20 | $42.70 | $42.59 | -0.26% | 0.7M |
| 05-21 | $42.59 | $40.87 | -4.04% | 1.8M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
Next report date, year-over-year trend, and recent quarter history.
Finnhub hasn't published the next scheduled earnings date yet. The list typically populates 4–8 weeks before the call.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Each factor shows VGNT's percentile within the scored universe — observational ranking, not a recommendation.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Past 1 reported quarters: EPS surprise vs estimate and the day-after-release stock reaction. Past performance does not predict future moves.
Sources: Finnhub earnings calendar + Polygon daily aggregates. Reaction direction can diverge from EPS surprise (guidance, macro, or sector flow can dominate the next-day print).
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $2.21B | $2.02B |
Operating Income | $74.00M | $123.00M |
Net Income | $78.00M | $95.00M |
EPS (Diluted) | Not available | Not available |
Total Assets | $4.91B | Not available |
Total Liabilities | $4.77B | Not available |
Cash & Equivalents | $282.00M | Not available |
Free Cash Flow OCF − CapEx | $-30.00M | $3.00M |
Shares Outstanding | Not available | Not available |
Versigent PLC designs and manufactures low- and high-voltage electrical architectures. Its products include signal, power, and data distribution systems used in sectors such as automotive, commercial vehicles, agriculture, and energy storage. The company operates engineering and manufacturing facilities across multiple regions and serves customers through an international network.
Fundamentals not available for VGNT yet.
We pull from FMP, Finnhub, and Polygon — common gaps are very recent IPOs that haven't filed their first 10-Q, pink-sheet OTC tickers, and foreign filers without US-listed depth. The Financials tab reads SEC EDGAR directly and may still have data here.
VGNT is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.